In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
about
In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivativeComparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.A review of the antimicrobial activity of the fluoroquinolones.The 4-quinolone antibiotics: past, present, and future.Mode of action, and in vitro and in vivo activities of the fluoroquinolones.Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.Difloxacin metabolism and pharmacokinetics in humans after single oral dosesPharmacokinetics of difloxacin in olive flounder Paralichthys olivaceus at two water temperatures.Macrolides: problems and promises.
P2860
Q35243584-372DAAFA-EF99-40D6-9BBE-6556CC657E07Q35288155-04D2F187-891A-4A25-BE7A-437F8AC58E7DQ35303163-57A782E0-29BD-462B-8333-AE376CF12423Q35340351-72F4CED2-6FC7-4761-BFCD-2FC25DD1CA01Q35346446-E9C3222A-30E6-40C8-8796-843231B7548FQ35543422-CCD1F19F-31EB-4839-B948-58917F72DABFQ35564364-16F5E829-4FAA-4F3E-ADFD-39BC5A6510D2Q35573087-273ACA56-DDD3-4FEF-B51B-C24B6E0B4C4BQ35653982-74847CE3-744F-4DA3-9186-C5DF031D8F19Q37834318-0B9E9FA6-8789-474A-8A18-B2D3C6A74862Q39314610-B70D31D4-B3F0-4D13-B5AF-33FDFBCE86FBQ39637667-DE10CAAD-9943-43EA-A4BB-500B6DA10CA1Q39827664-72ACEDAB-47C3-4BC6-93FD-B209E8EC59AFQ39834941-CDF4B367-196D-4846-845F-CBE7A6B4CA8AQ42602439-39FFA2FD-8925-4F1D-8D09-8D5DB6D5D614Q54388935-08D33DC8-16C5-41F4-9B9E-6F6408DAF170
P2860
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
@en
In vitro evaluation of A-56619
@nl
type
label
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
@en
In vitro evaluation of A-56619
@nl
prefLabel
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
@en
In vitro evaluation of A-56619
@nl
P2093
P2860
P356
P1476
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.2.193
P407
P577
1986-02-01T00:00:00Z